Shanghai, China

Xia Shi

This inventor holds 2 USPTO granted patents. Top assignees: Delta Electronics (Shanghai) Co., Ltd., Shanghai Haiyan Pharmaceutical Technology Co., Ltd., Yangtze River Pharmaceutical Group Co., Ltd.. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xia Shi. Retrieved from https://idiyas.com/inventor/xia-shi-sx29hsvj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2020-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Xia Shi in Pharmaceutical Chemistry

Introduction

Xia Shi is a notable inventor based in Shanghai, China, recognized for his contributions to pharmaceutical chemistry. He holds a patent that showcases his innovative approach to drug development, particularly in the area of pain management.

Latest Patents

Xia Shi's most recent patent is focused on benzobicycloalkane derivatives, their preparation, and pharmaceutical use. The patent details a compound of Formula (I), along with its pharmaceutically acceptable salts, stereoisomers, or solvates. This invention provides a method for preparing these compounds and highlights their potential use in developing drugs aimed at treating pain.

Career Highlights

Throughout his career, Xia Shi has worked with prominent companies in the pharmaceutical sector, including Shanghai Haiyan Pharmaceutical Technology Co., Ltd. and Yangtze River Pharmaceutical Group Co., Ltd. His work in these organizations has contributed significantly to advancements in drug formulation and therapeutic applications.

Collaborations

Xia Shi has collaborated with notable colleagues in the field, including Fusheng Zhou and Shuchun Guo, who is a woman. These collaborations have fostered a productive environment for innovation and research in pharmaceutical sciences.

Conclusion

Xia Shi's contributions to the field of pharmaceutical chemistry, particularly through his patent on benzobicycloalkane derivatives, demonstrate his commitment to advancing drug development for pain management. His work continues to influence the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…